tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Financial Statements

Compare
23 Followers

Rapport Therapeutics, Inc. Financial Overview

Rapport Therapeutics, Inc.'s market cap is currently $475.49M. The company's EPS TTM is $; its P/E ratio is ―; Rapport Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ -112.00K$ -15.00K
Operating Income$ -36.18M$ -10.37M
EBITDA$ -34.66M$ -10.35M
Net Income$ -34.79M$ -10.65M
Balance Sheet
Cash & Short-Term Investments$ 147.56M$ 31.16M
Total Assets$ 155.42M$ 31.60M
Total Debt$ 2.15M$ 0.00
Net Debt$ -68.02M$ -31.16M
Total Liabilities$ 14.48M$ 12.10M
Stockholders' Equity$ 140.94M$ 19.50M
Cash Flow
Free Cash Flow$ -28.82M$ -3.53M
Operating Cash Flow$ -27.18M$ -3.24M
Investing Cash Flow$ -78.86M$ -5.28M
Financing Cash Flow$ 145.14M$ 39.69M
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History

Rapport Therapeutics, Inc. Debt to Assets

Rapport Therapeutics, Inc. Cash Flow

Rapport Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis